• Eiger BioPharmaceuticals Halts Clinical Development of Ubenimex for PAH
  • Heart Blood Pressure Tool Unable to Predict Survival of PAH Patients on Remodulin, Study Finds
  • French Team Links Certain Antibodies to Improved Survival of PAH Patients with Lupus
  • The Importance of Acknowledging Warning Signs from Our Bodies
  • United Therapeutics and Corsair to Work Together on Skin Patch to Deliver Pulmonary Hypertension Therapy
  • PHighting Beyond Life Expectancy
  • Prepared for the Worst
  • Multi-category Index Can Predict Adempas-treated PAH Patients’ Outcomes, Study Finds
  • Online Dating and Intimate Disclosures
  • Liquidia Starts Phase 3 Clinical Trial of Pulmonary Hypertension Treatment
  • Bellerophon Enrolls First Patient in Phase 2b Trial of INOpulse as Treatment for ILD-linked PH
  • This New Year, Choose Kindness and Spread Positivity